Wound Debridement Products Market, By Product Type (Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices, and Larval Therapy), By Application (Chronic Ulcers, Surgical Wounds, Traumatic Wounds, and Burn Cases) by End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Others (Nursing Facilities, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI3784

Pages :180

Formats :

Excel and PDF

Industry : Medical Devices

Wound Debridement Products MarketSize and Trends

Global wound debridement products market is estimated to be valued at US$ 779.9 million in 2023 and is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030).

Figure 1. Global Wound Debridement Products Market Share (%), By Product Type, 2023

Figure 2. Global Wound Debridement Products Market Value (US$ Million), By Region, 2023

Global Wound Debridement Products Market – Drivers

Increasing Collaborations among Key Market Players

Increasing adoption of inorganic strategies such as collaborations among key market players is expected to drive the global wound debridement products market over the forecast period. For instance, on March 8, 2023, Ceapro Inc., a Canada-based biotechnology company, announced that its study in collaboration with The Angiogenesis Foundation, non-profit organization in U.S., on Avena Sativa derived therapeutics β-Glucan and Avenanthramide was accepted for presentation at annual meeting of wound healing society held at Canada. It was found that oats (Avena Sativa) can accelerate wound healing in mice by anti-inflammatory mechanisms, and can reduce scar formation. It can stimulate angiogenesis.

Increasing Awarenss Programs by Key Market Players

In June 2021, Sanara MedTech Inc., a U.S.-based surgical and chronic wound care product provider company, announced a partnership with Pixalere Healthcare Inc., a Canada-based wound care software company, to advance its comprehensive wound and skin care strategy. The aim of this partnership is to use Pixalere’s technology including decision support, documentation, and wound tracking analytics, with complementary Sanara solutions that offer virtual access to expert wound and skin physicians, advanced diagnostics, and wound care product order fulfillment.